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Abstract
To gain insights into the working mechanism of morphine, regional cerebral blood flow (rCBF) patterns after morphine
administration were assessed in dogs. In a randomized cross-over experimental study, rCBF was estimated with 99mTc-
Ethylcysteinate Dimer single photon emission computed tomography in 8 dogs at baseline, at 30 minutes and at 120
minutes after a single bolus of morphine. Perfusion indices (PI) in the frontal, parietal, temporal and occipital cortex and in
the subcortical and cerebellar region were calculated. PI was significantly decreased 30 min after morphine compared to
baseline in the right frontal cortex. The left parietal cortex and subcortical region showed a significantly increased PI 30 min
after morphine compared to baseline. No significant differences were noted for the other regions or at other time points. In
conclusion, a single bolus of morphine generated a changing rCBF pattern at different time points.
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Introduction
Morphine, a mu opioid receptor agonist, is a frequently used
potent analgesic in human and veterinary medicine. Its pharma-
cological effect depends on peripheral and supraspinal mu opioid
receptor (MOR) activation (for review see [1]). Cerebral MORs
are widely distributed throughout the brain and modulate the
transmission and perception of painful stimuli [2].
Numerous studies have reported on different aspects of the
influence of various opioids on cerebral hemodynamics, both in
animal models and in man [3–10]. However, the effects of opioids
on cerebral blood flow (CBF) remain unclear due to the variable
results [3–10]. In dogs, only few have reported on the
hemodynamic effects of morphine on the brain, usually reporting
global cerebral blood flow changes with varying results [4,11–16].
These discrepancies are probably caused by differences in study
design, imaging technique, species, opioid choice, dose and route
of administration.
It is important to determine whether regional CBF (rCBF)
differences occur in order to better understand how drugs
influence cerebral activity and, therefore, to gain insight on their
mechanism of action. Particularly in the case of mu opioid
analgesics this is interesting since their side effects (dependence,
tolerance, addiction) are thought to be mainly caused by
supraspinal mechanisms in which the MOR plays a key role [17].
Single photon emission computed tomography (SPECT) imag-
ing using 99mTc-Ethylcysteinate Dimer (99mTc-ECD) is a valid
method for rCBF evaluation in dogs [18]. As rCBF is correlated to
regional brain activity [19], it can be used to study the effects of
different drugs on the canine brain [20]. The objective of the
present study was to examine the effects of a single dose of
morphine on rCBF in dogs. Since opiate action is not only dose,
but also time dependent [21,22], SPECT scans were performed at
different time intervals after morphine administration.
Materials and Methods
Animals
Eight female neutered Beagle dogs (age 4.2260.35 years, weight
8.5860.87 kg (mean 6 standard deviation, SD)) were used for this
study. None of the dogs had a history of major disease or
neurological disorder. The study was approved by the Ghent
University Ethical Committee (EC 2011-130). All guidelines for
animal welfare, imposed by the Ethical Committee, were strictly
respected. All procedures were conducted under veterinarian
supervision. The animals were housed in pairs in pens and
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received environmental enrichment. Food was provided once daily
and water was given ad libitum.
Study Design
To investigate the influence of a single rapid bolus of morphine
(0.5 mg/kg intravenously, Morphine Hydrochloride, Sterop,
Belgium) on rCBF, all dogs were scanned 3 times in a randomized
cross-over study design. The 3 SPECT scans consisted of a
baseline scan (no morphine, condition ‘Baseline’), a scan where
99mTc-ECD was injected 30 minutes after morphine (i.e. T30,
condition ‘MOR30’) and a scan where 99mTc-ECD was injected
120 minutes after morphine (i.e. T120, condition ‘MOR120’). The
time between scans was 3 weeks. All scans were performed
following the same anesthetic and image acquisition protocol.
Food, but not water, was withheld for 12 hours before each scan,
to reduce the risk of aspiration during anesthesia. To determine
morphine plasma and cerebrospinal fluid (CSF) concentrations
2 hours after morphine administration, 5 mL of blood were
collected from the jugular vein (in a heparinized blood tube) and
approximately 2 mL of CSF were collected by cisternal puncture
from all dogs under anesthesia after the MOR30 scan. Blood was
centrifuged at 3500 rpm for 5 minutes after which plasma was
collected. All samples were kept at 220uC until analysis was
performed.
Tracer
To evaluate rCBF 99mTc-ECD (Neurolite, Bristol-Myers Squibb
Medical Imaging), prepared according to the manufacturer’s
instructions, was used. 99mTc-ECD passes the blood-brain-barrier
in its lipophilic form after which it is enzymatically transformed by
intracellular esterases to a hydrophilic form that remains trapped
in the cell. It rapidly reaches plateau values in the brain from
5 min onwards thus providing a fixed image of the rCBF
practically at the moment of 99mTc-ECD injection. Optimal
image acquisition is achieved between 15 and 40 min after tracer
injection [23]. In the present study, image acquisition was started
40 min after injection of the tracer. 99 mTc-ECD was administered
intravenously: 747.91630.22 MBq, 789.16647.02 MBq and
751.61640.33 MBq in the Baseline, MOR30 and MOR120
condition, respectively.
Anesthetic Protocol
General anesthesia is required for SPECT imaging in animals.
Prior to the study, an intravenous catheter was placed to ensure
correct drug administration. To avoid the influence of anesthetic
drugs on rCBF, the administration of the anesthetics was done
after the plateau for 99mTc-ECD was reached in the canine brain.
All dogs were sedated prior to general anesthesia with intramus-
cular dexmedetomidine 375 mg/m2 body surface area (Dexdomi-
tor, Orion Corporation, Espoo, Finland). After induction with
intravenous propofol (Propovet, Abbott Laboratories, Queen-
borough, United Kingdom), the dogs were intubated and
anaesthesia was maintained with isoflurane (Isoflo, Abbott
Laboratories) in oxygen. Acquisition started 10 minutes after
induction of anesthesia. The dogs were monitored during
anesthesia and were mechanically ventilated by intermittent
positive pressure ventilation to maintain eucapnia, i.e. end tidal
CO2 within 35–45 mmHg, in order to limit the influence of the
PaCO2 on cerebral perfusion. After the SPECT scan, the dogs
were monitored during the recovery period. The procedure was
well tolerated by all animals. The administration of morphine
induced a short period of panting and mild sedation in some dogs,
as was expected. No other side effects were noted during the
experiments.
Image Acquisition
Image acquisition started 10 minutes after induction of
anesthesia, i.e. 40 min after 99mTc-ECD injection. Circular orbit
SPECT scans were performed using a triple head gamma camera
(Triad Trionix, Twinsburg, OH, USA) equipped with ultrahigh
resolution parallel hole collimators (tomographic resolution, 8 mm
full width half maximum). For each acquisition, 120 projection
images were obtained on a 1286128 matrix using a step-and-shoot
mode (360u angular sampling, 3u steps, 10 s per step), with a total
scanning time of 20 minutes. A 20% window setting, centered
symmetrically on the photon energy of 99mTc (140keV), was used.
During scanning, dogs were positioned in ventral recumbence with
fixation of the head in a preformed cushion, to prevent individual
positioning artifacts. Camera and table positioning were recorded
to ensure optimal intraindividual comparison.
Image Processing
The images were reconstructed using filtered backprojection
and post-filtering with a Butterworth filter (cut-off, 1.6 cycles/cm,
order 5). Pixel size was 1.72 mm. Average whole brain counts
registered in the blank scan, MOR 30 and MOR 120 scans were
9958306305258, 11838676314715 and 10175986418056 re-
spectively.
The emission data were fitted to a template, which provides
anatomical references and a predefined region map, with BRASS
software (Brain Registration and Automated SPECT Semiquanti-
fication, Hermes Gold (version 2.10), Nuclear Diagnostics, Stock-
holm, Sweden). This software allows scaling, rotating, and
translating the acquired images in all 3 dimensions in order to
fit them to this template. It was originally developed for humans
but the template and regions were created in house for the use in
dogs [24]. Using this template with the predefined region map,
allows for a volume-of-interest (VOI) approach. The following
VOIs were included: right and left frontal, temporal, parietal and
occipital cortices, as well as the subcortical and cerebellar region.
Perfusion indices (PI) for the different VOIs were calculated as the
mean count per voxel in each VOI normalized to the mean total
brain count per total voxel.
Morphine Concentrations
Plasma and CSF concentrations of morphine were determined
using a validated liquid chromatography-tandem mass spectrom-
etry (LC-MS/MS) method, as previously described by Gadeyne et
al. [25]. Quality control (QC) and blank samples were analyzed
together with each batch of incurred samples to check the
extraction and LC-MS/MS procedure. All QC, blank and
calibration curve samples were prepared in pooled drug-free dog
plasma. The limit of detection of the method was calculated to be
1.27 ng/mL based on a signal-to-noise ratio of 3/1. The accuracy
and precision were determined at 10.0 and 50.0 ng/mL in dog
plasma (n = 6). The accuracy fell within the range of 220% to +
10%, and precision was also within the maximum RSD values as
set by the EU [26]. The limit of quantification (LOQ) was defined
as the lowest concentration in dog plasma for which the method
was validated with an accuracy and precision that fall within EU
recommended ranges and was set at 5.0 ng/mL. Plasma and CSF
concentrations below the LOQ were not included in the data
analysis.
Statistical Analysis
To compare PI means between the three conditions, a mixed
model was fitted with condition (Baseline, MOR30 and MOR120)
as fixed effect and dog as random effect. Left-right differences for
Morphine Alters rCBF in Dogs
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the cortical regions were calculated by means of non-parametric
Wilcoxon Signed Ranks Test. Correlation between morphine
plasma and CSF concentration was investigated by means of
Kendall Tau b correlation coefficients.
Significance was set at P,0.05. All data are presented as mean
6 SD.
Results
Table 1 depicts PIs for all VOIs in the different conditions.
Mean PIs of the right frontal cortex, left parietal cortex and the
subcortical region differed significantly between conditions.
Pairwise comparison revealed that morphine administration only
altered the rCBF in those regions compared to the baseline
condition at T30 (P=0.047, 0.021 and 0.006 respectively). No
significant differences were found when comparing Baseline to
MOR120 or MOR30 to MOR120.
Table 2 shows the mean left-right differences for the frontal,
temporal, parietal and occipital cortices. Significant left-right
differences were found in the forntal cortex for all conditions and
in the occipital cortex in the MOR30 condition.
Two CSF samples had morphine concentrations below the
LOQ and were not used for further analysis. Morphine plasma
and CSF concentrations 2 hours after morphine administration
were 13.5063.75 ng/mL and 17.5261.32 ng/mL, respectively
(individual concentrations are presented in Table 3). There was no
significant correlation between morphine concentrations in plasma
and CSF (Kendall Tau correlation coefficient 0.43 and P=0.14).
Discussion
The current study investigated changes in rCBF after morphine
administration in dogs at two different time points. In non-painful
dogs, a single dose of morphine induced rCBF changes in the
frontoparietal cortex after 30 minutes compared to baseline values.
We found a decrease in blood flow in the frontal cortex and an
increase in blood flow in the parietal cortex. These brain regions
are known to be involved in the complex mechanism of pain
perception, i.e. the cognitive and affective-motivational aspects of
nociception (for review see [27]). The parietal lobes are part of the
somatosensory systems, playing a role in not only the perception of
painful and non-painful stimuli, but also in their modulation.
Additionally, a study in rats provided evidence in the role of the
somatosensory areas in the induction of morphine addiction,
where lesions in these regions would impair conditioned place
preference [28].
Additionally, an increased CBF was found in the subcortical
region which includes structures important for pain modulation
such as the thalamus and the periaqueductal gray (for review see
[29]). Alterations in rCBF reflect alterations in brain activity, i.e.
increased brain activity requires increased blood supply and vice
versa [19]. It is therefore not surprising to find rCBF changes in
regions involved in the modulation and perception of pain after
the administration of a potent analgesic such as morphine.
Furthermore, the present results are in line with a study in humans
on the effects of opioids and provoked pain on rCBF [9]. In that
study it was found that regions involved in the modulation of pain
were activated, whereas regions that are involved in the perception
of pain showed a decreased rCBF after opioid administration [9].
In dogs, the effects of opioids on global CBF have been
investigated and decreased as well as increased global CBF have
been reported [12,15,16].
Remarkably, we only found a significant difference in rCBF
between MOR30 and Baseline and not between MOR120 and
Baseline. In a study in dogs using remifentanil, decreased blood
flow and decreased EEG activity were described in the cortex,
hippocampus and caudate nucleus [4]. These changes recovered
to baseline levels after 30 minutes [4]. Since morphine is a longer
acting opioid, with a halftime of approximately 60 minutes in dogs
at the same intravenous dosage of 0.5 mg/kg [30], it is possible
that a comparable return to baseline brain activity occurs at a later
time point.
The morphine plasma concentrations at T120 were
13.5063.75 ng/mL, these are comparable to the plasma concen-
trations needed to achieve 50% of maximal effect obtained in a
pharmacodynamic study in dogs using 1 mg/kg morphine IV, i.e.
13.9262.39 ng/mL [31]. In that study it was also reported that a
significant analgesic level was present for only 2.860.6 hours [31].
In a clinical setting on the other hand, morphine is usually
administered every 4 hours to maintain proper analgesia. Indeed,
recommended morphine dosages in dogs range from 0.1 to
0.5 mg/kg intravenously, with lasting effects up to 3 to 4 hours
[32]. In a study in dogs on the pharmacokinetics of morphine,
CSF concentrations at T120 were higher than plasma concentra-
tions, as is the case in our study for most dogs and the range of
Table 1. Perfusion indices for the different conditions (Baseline, MOR30 and MOR120) in all volumes of interest (VOI) in 8 dogs
(mean 6 SD).
VOI Baseline MOR30 MOR120 P
LF 1.1260.05 1.1260.06 1.1260.04 0.89
RF 1.1260.02 1.0660.07 1.1160.04 0.04*
LT 0.8660.02 0.9060.07 0.8960.05 0.23
RT 0.8560.05 0.8560.04 0.9060.05 0.09
LP 1.1260.07 1.2160.06 1.1960.07 0.02*
RP 1.1160.04 1.1560.10 1.2060.09 0.08
LO 1.0860.07 1.0960.13 1.0060.07 0.12
RO 1.0760.05 1.0760.14 1.0260.08 0.36
Subcortical 1.2460.03 1.2960.04 1.2660.05 0.01*
Cerebellum 1.0560.02 1.0460.06 1.0060.06 0.14
Data compared with mixed model. *Pairwise comparisons revealed a significant difference between Baseline and MOR30 in RF, LP and SC (P= 0.047, 0.021 and 0.006
respectively). LF, left frontal; RF, right frontal; LT, left temporal; RT, right temporal; LP, left parietal; RP, right parietal; LO, left occipital; RO, right occipital.
doi:10.1371/journal.pone.0109680.t001
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CSF concentrations at T120 are also comparable to our results
(Table 3) [33]. It was additionally described that morphine
appears to accumulate in CSF over time after systemic adminis-
tration, since it has a longer halftime in CSF (12166 min)
compared to plasma (7565 min) and the CSF-to-plasma concen-
tration gradient increases progressively [33]. Therefore, a single
dose of morphine will have plasma concentrations that decrease
more rapidly than CSF concentrations, leading to an underesti-
mation of the effective plasma concentrations after the adminis-
tration of a single dose of morphine.
Taken together with our results, at T120 after morphine
administration, we know that plasma and CSF concentrations are
present and effective, however, no changes in blood flow – and
thus brain activity – are detectable at this time point. This could
possibly suggest that morphine exerts its effect at a different level at
this time point. On the one hand, changes in the serotonergic
neuroreceptor system have been found in a previous study,
possibly indicating that the downstream effects of morphine are
more important for its effect [34]. On the other hand, a peripheral
action (spinal or at the periphery) rather than a supraspinal action
could be responsible for the effect of morphine at a later time
point. This possibly insinuates a time-dependent localization of the
analgesic effect of morphine, which would be interesting for
further investigation in future studies.
Differences in perfusion were found when comparing the left
and right frontal cortices in all conditions. Seeing as this is
consistent throughout the conditions, a specific effect due to the
administration of morphine is unlikely. For the found elevated
blood flow in the left occipital region compared to the right
occipital region in the MOR30 condition we do not have a clear
explanation.
As for the effects of opioids on cerebral hemodynamics in dogs,
it is rather unlikely that changes in systemic cardiovascular
parameters would cause regional alterations in CBF. Next to the
fact that morphine at clinically relevant doses has limited influence
on systemic cardiovascular parameters such as heart rate and
blood pressure [35,36], circulatory changes would be expected to
cause more global CBF changes that cannot be properly assessed
with the technique used in the present study.
Additionally, if proper ventilation is assured (opioids can cause
respiratory depression), the effects of opioids on cerebral
hemodynamics are limited when used at clinical doses [37].
Several explanations for the alterations in rCBF caused by
opioids have been suggested. The observed rCBF changes are
most likely the result of changes in neuronal activity since MOR
activation in itself requires increased energy demand, thus
increasing blood flow. An effect of opioids on cerebral vasculature
has also been proposed, either direct or indirect [38,39]. However,
this would imply that changes in rCBF are only related to MOR
density, which is not always the case due to the widespread
distribution of cerebral MORs [2,5,40,41] and the widespread
influence of opioids on different neurotransmitter systems [42–44].
Conclusion
The present study found an altered rCBF pattern 30 minutes
after morphine compared to baseline values. Pain is a complex
phenomenon and unraveling the working mechanism of analgesics
such as opioids appears to be equally challenging, involving
various cerebral regions. On top of this, the possibly time-
dependent rCBF pattern found after morphine raises new
questions on the correct interpretation of data and the comparison
with other results.
Table 2. Differences (mean 6 SD) between perfusion indices of left and right cortical regions in 8 dogs in the different conditions
(Baseline, MOR30 and MOR120).
Baseline MOR30 MOR120
LF-RF 0.0060.05* 0.0560.05* 0.0160.05*
LT-RT 0.0160.04 0.0560.07 0.0060.07
LP-RP 0.0260.07 0.0660.06 20.0160.09
LO-RO 0.0160.04 0.0160.05* 20.0160.07
*Significant difference between left and right region (P,0.05).
doi:10.1371/journal.pone.0109680.t002
Table 3. Morphine concentrations (ng/mL) in plasma and CSF in 8 dogs 120 minutes after intravenous morphine administration at










LOQ: Limit of quantification.
doi:10.1371/journal.pone.0109680.t003
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